Live Breaking News & Updates on Vectivbio

Stay updated with breaking news from Vectivbio. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Analyzing TScan Therapeutics (NASDAQ:TCRX) & VectivBio (NASDAQ:VECT)

VectivBio (NASDAQ:VECT – Get Free Report) and TScan Therapeutics (NASDAQ:TCRX – Get Free Report) are both medical companies, but which is the superior business? We will contrast the two businesses based on the strength of their valuation, profitability, institutional ownership, earnings, dividends, risk and analyst recommendations. Risk & Volatility VectivBio has a beta of 0.08, […] ....

United States , Ironwood Pharmaceuticals Inc , Tscan Therapeutics Inc , Vectivbio Holding , Novartis Institutes For Biomedical Research Inc , Get Free Report , Ironwood Pharmaceuticals , Novartis Institutes , Biomedical Research , Vectivbio Daily , Nasdaq Vect , Stock Comparison , Stock Analysis ,

Virtu Financial LLC Acquires New Position in VectivBio Holding AG (NASDAQ:VECT)

Virtu Financial LLC purchased a new stake in VectivBio Holding AG (NASDAQ:VECT – Free Report) in the 2nd quarter, according to the company in its most recent Form 13F filing with the SEC. The institutional investor purchased 41,411 shares of the company’s stock, valued at approximately $699,000. Other hedge funds have also made changes to […] ....

Marshall Wace , Gilder Gagnon Howe Co , Virtu Financial , Citadel Advisors , Regency Capital Management Inc , Harvest Management , Vectivbio Company Profile , Vectivbio Holding , Free Report , Capital Management , Gilder Gagnon Howe , Bio Holding , Visit Holdingschannel , Vectivbio Daily , Nasdaq Vect , Sec Filings , Hedge Fund Holdings , Institutional Investor Holdings ,

VectivBio (NASDAQ:VECT) Sets New 1-Year High at $16.85

Shares of VectivBio Holding AG (NASDAQ:VECT – Get Rating) reached a new 52-week high during trading on Thursday . The stock traded as high as $16.85 and last traded at $16.75, with a volume of 104461 shares trading hands. The stock had previously closed at $16.72. Analysts Set New Price Targets Several analysts have recently […] ....

United States , Piper Sandler , Wells Fargo Company , Vectivbio Holding , America Corp , Geode Capital Management , Regency Capital Management Inc , Barclays Plc , Credit Suisse Group , Vectivbio Company Profile , Get Rating , Suisse Group , Capital Management , Regency Capital Management , Vectivbio Daily , Nasdaq Vect ,

VectivBio (NASDAQ:VECT) Cut to "Market Perform" at SVB Securities

SVB Securities cut shares of VectivBio (NASDAQ:VECT – Get Rating) from an outperform rating to a market perform rating in a report issued on Tuesday morning, The Fly reports. A number of other equities analysts also recently commented on VECT. Piper Sandler boosted their target price on shares of VectivBio from $23.00 to $25.00 and […] ....

Piper Sandler , Vectivbio Company Profile , Driehaus Capital Management , Vr Adviser , Vivo Capital , Marshall Wace , Vectivbio Holding , Frazier Life Sciences Management , Credit Suisse Group , Get Rating , Suisse Group , Moderate Buy , Capital Management , Vectivbio Daily , Nasdaq Vect , Svb Securities ,